Skip to main content
Top
Published in: Rheumatology International 9/2009

01-06-2009 | Original Article

Ulnar artery vasculopathy in systemic sclerosis

Authors: Jeong Ha Park, Yoon-Kyoung Sung, Sang-Cheol Bae, Soon-Young Song, Heong Seok Seo, Jae-Bum Jun

Published in: Rheumatology International | Issue 9/2009

Login to get access

Abstract

Although digital ulceration frequently occurs in patients with systemic sclerosis, there have been few reports on macrovascular involvement. Macrovascular disease in systemic sclerosis has recently been described. We retrospectively reviewed the medical records and brachial angiographic findings of 19 systemic sclerosis patients, who exhibited Raynaud’s phenomenon and digital ulceration. We found that ulnar artery involvement is frequent in systemic sclerosis, although the precise mechanism is not known. There was no significant difference in risk factors of macrovascular disease between ulnar artery-involved patients and not-involved subjects. Thirteen patients underwent surgical intervention; five of the 13 patients had vascular graft performed due to ulnar artery involvement. We suggest that angiographic screening and early surgical intervention such as revascularization should be considered in patients with systemic sclerosis who manifest a severe form of Raynaud’s phenomenon and/or digital ulceration and especially in patients with diffuse sclerosis.
Literature
5.
go back to reference Taylor MH, McFadden JA, Bolster MB, Silver RM (2002) Ulnar artery involvement in systemic sclerosis (scleroderma). J Rheumatol 29:102–106PubMed Taylor MH, McFadden JA, Bolster MB, Silver RM (2002) Ulnar artery involvement in systemic sclerosis (scleroderma). J Rheumatol 29:102–106PubMed
6.
go back to reference Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic, Therapeutic Criteria Committee (1980) Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 23:581–590CrossRef Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic, Therapeutic Criteria Committee (1980) Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 23:581–590CrossRef
7.
go back to reference Youssef P, Englert H, Bertouch J (1993) Large vessel occlusive disease associated with CREST syndrome and scleroderma. Ann Rheum Dis 52:464–466PubMedCrossRef Youssef P, Englert H, Bertouch J (1993) Large vessel occlusive disease associated with CREST syndrome and scleroderma. Ann Rheum Dis 52:464–466PubMedCrossRef
8.
go back to reference Youssef P, Brama T, Englert H, Bertouch J (1995) Limited scleroderma is associated with increased prevalence of macrovascular disease. J Rheumatol 22:469–472PubMed Youssef P, Brama T, Englert H, Bertouch J (1995) Limited scleroderma is associated with increased prevalence of macrovascular disease. J Rheumatol 22:469–472PubMed
9.
go back to reference Veale DJ, Collidge TA, Belch JJ (1995) Increased prevalence of symptomatic macrovascular disease in systemic sclerosis. Ann Rheum Dis 54:853–855PubMedCrossRef Veale DJ, Collidge TA, Belch JJ (1995) Increased prevalence of symptomatic macrovascular disease in systemic sclerosis. Ann Rheum Dis 54:853–855PubMedCrossRef
10.
go back to reference Stafford L, Englert H, Gover J, Bertouch J (1998) Distribution of macrovascular disease in scleroderma. Ann Rheum Dis 57:476–479PubMedCrossRef Stafford L, Englert H, Gover J, Bertouch J (1998) Distribution of macrovascular disease in scleroderma. Ann Rheum Dis 57:476–479PubMedCrossRef
12.
go back to reference Stucker M, Quinna S, Memmel U, Rochling A, Traupe M, Hoffmann K et al (2000) Macroangiopathy of the upper extremities in progressive systemic sclerosis. Eur J Med Res 5:295–302PubMed Stucker M, Quinna S, Memmel U, Rochling A, Traupe M, Hoffmann K et al (2000) Macroangiopathy of the upper extremities in progressive systemic sclerosis. Eur J Med Res 5:295–302PubMed
13.
Metadata
Title
Ulnar artery vasculopathy in systemic sclerosis
Authors
Jeong Ha Park
Yoon-Kyoung Sung
Sang-Cheol Bae
Soon-Young Song
Heong Seok Seo
Jae-Bum Jun
Publication date
01-06-2009
Publisher
Springer-Verlag
Published in
Rheumatology International / Issue 9/2009
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-009-0906-7

Other articles of this Issue 9/2009

Rheumatology International 9/2009 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.